Amphastar Pharmaceuticals (NASDAQ:AMPH) Raised to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Piper Sandler boosted their price target on Amphastar Pharmaceuticals from $43.00 to $55.00 in a research note on Thursday, June 15th. Amphastar Pharmaceuticals Stock Down 2.1 % […]

Related Keywords

United States ,Montreal ,Quebec ,Canada ,China ,France ,Williamj Peters ,Floydf Petersen ,Piper Sandler ,York Mellon Corp ,Amphastar Pharmaceuticals Stock Down ,Amphastar Pharmaceuticals ,Amphastar Pharmaceuticals Inc ,Citigroup Inc ,News Ratings For Amphastar Pharmaceuticals Daily ,Raymond James Associates ,Envestnet Asset Management Inc ,Get Rating ,Pharmaceuticals Stock Down ,Director Floyd ,Asset Management ,New York Mellon Corp ,Montreal Can ,Finished Pharmaceutical Products ,Active Pharmaceutical Ingredient ,Amphastar Pharmaceuticals Daily ,Nasdaq Amph ,Amph ,Medical ,Upgrade ,Stocknews Com ,